Genome Valley Excellence Award 2026 to be conferred upon Dr Bruce Levine at BioAsia
Dr Bruce Levine of the University of Pennsylvania will receive the Genome Valley Excellence Award 2026 at BioAsia for his groundbreaking work in cell and gene therapy, particularly CAR T-cell treatments for cancer. His innovations have significantly advanced personalized medicine and cancer immunotherapy, setting new benchmarks for translational research and global healthcare.
Dr Bruce Levine of the University of Pennsylvania will receive the Genome Valley Excellence Award 2026 at BioAsia for his groundbreaking work in cell and gene therapy, particularly CAR T-cell treatments for cancer. His innovations have significantly advanced personalized medicine and cancer immunotherapy, setting new benchmarks for translational research and global healthcare.
